SCHEMBL7494535

SCHEMBL7494535

CCOC(=O)COc1cccc2c1CCC[C@H]2NCc1nc(-c2ccccc2)c(-c2ccccc2)o1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGIR P43119 1/20 0.49
NR4A2 P43354 7/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 2/20 0.40
ALDH1A1 P00352 1/20 0.40
PPARD Q03181 1/20 0.39
KMT2A Q03164 2/20 0.39
CD274 Q9NZQ7 1/20 0.38
LMNA P02545 1/20 0.38
NR4A1 P22736 2/20 0.37
NR4A3 Q92570 2/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
ACHE P22303 1/20 0.37
TAS1R3 Q7RTX0 1/20 0.37
TAS1R1 Q7RTX1 1/20 0.37
TAS1R2 Q8TE23 1/20 0.37
MEN1 O00255 1/20 0.37
GAA P10253 1/20 0.37
RXRA P19793 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7488605 1.00 PTGIR (0.49) PTGIRNR4A2KDM4EHPGDALDH1A1
SCHEMBL7494415 0.95 PTGIR (0.45) PTGIRNR4A2KDM4EHPGDALDH1A1
SCHEMBL7493142 0.90 PTGIR (0.53) PTGIRNR4A2KDM4EHPGDPPARD
SCHEMBL7493344 0.90 PTGIR (0.53) PTGIRNR4A2KDM4EHPGDPPARD
SCHEMBL8546090 0.86 PTGIR (0.46) PTGIRKDM4EHPGDALDH1A1KMT2A
SCHEMBL7485190 0.85 NR4A2 (0.50) PTGIRNR4A2KDM4EHPGDALDH1A1
SCHEMBL7485549 0.85 PTGIR (0.49) PTGIRNR4A2KDM4EHPGDPPARD
SCHEMBL7497329 0.85 PTGIR (0.49) PTGIRNR4A2KDM4EHPGDALDH1A1
SCHEMBL7498903 0.85 PTGIR (0.49) PTGIRNR4A2KDM4EHPGDALDH1A1
SCHEMBL7481679 0.84 PTGIR (0.48) PTGIRKDM4EHPGDALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1213285-A2 4,5-dipheny-oxazole derivatives and their use as platelet aggregation inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-06-12 EP disclosed
US-6300344-B1 FOR THERAPEUTIC AND/OR PROPHYLACTIC TREATMENT OF ARTERIAL OBSTRUCTION, CEREBROVASCULAR DISEASE, HEPATIC CIRRHOSIS, ARTERIOSCLEROSIS, ISCHEMIC HEART DISEASE, RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY, HYPERTENSION FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-09 US disclosed
US-5972965-A USEFUL FOR INHIBITION OF PLATELET AGGREGATION, VASODILATION, ANTIHYPERTENSIVE ACTIVITY AND PROSTAGLANDIN AGONIST FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-26 US disclosed
WO-1997003973-A1 4,5-DIARYL OXAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-02-06 WO disclosed